Foetal therapies and their influence on preterm birth
Author(s) -
Ignacio Valenzuela,
Johannes van der Merwe,
Luc De Catte,
Roland Devlieger,
Jan Deprest,
Liesbeth Lewi
Publication year - 2020
Publication title -
seminars in immunopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.778
H-Index - 94
eISSN - 1863-2300
pISSN - 1863-2297
DOI - 10.1007/s00281-020-00811-2
Subject(s) - hysterotomy , medicine , limiting , in utero , intensive care medicine , fetoscopy , obstetrics , pregnancy , fetus , psychological intervention , prenatal diagnosis , mechanical engineering , genetics , psychiatry , engineering , biology
Foetal therapy aims to improve perinatal survival or to prevent severe long-term handicap. Foetal medicine opens a new territory by treating the foetus as a patient. The mother has nothing to gain in terms of health benefits, yet she is inherently also undergoing treatment. In utero foetal interventions can be divided into ultrasound-guided minimally invasive procedures, fetoscopic procedures and open hysterotomy procedures, which carry an inherent risk of ruptured membranes and preterm birth. In this review, we summarise the conditions that may benefit from foetal therapy and review the current therapies on offer, each with their associated risk of ruptured membrane and preterm birth. We also look into some risk limiting and preventative strategies to mitigate these complications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom